Catherine C. Turkel
2018
In 2018, Catherine C. Turkel earned a total compensation of $625.5K as President at Tokai Pharmaceuticals, a 9% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $118,965 |
|---|---|
| Option Awards | $81,272 |
| Salary | $357,673 |
| Stock Awards | $64,661 |
| Other | $2,930 |
| Total | $625,501 |
Turkel received $357.7K in salary, accounting for 57% of the total pay in 2018.
Turkel also received $119K in non-equity incentive plan, $81.3K in option awards, $64.7K in stock awards and $2.9K in other compensation.
Rankings
In 2018, Catherine C. Turkel's compensation ranked 11,131st out of 14,244 executives tracked by ExecPay. In other words, Turkel earned more than 21.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,131 out of 14,244 | 22nd |
Division Manufacturing | 4,490 out of 5,758 | 22nd |
Major group Chemicals And Allied Products | 1,698 out of 2,119 | 20th |
Industry group Drugs | 1,438 out of 1,808 | 21st |
Industry Pharmaceutical Preparations | 1,101 out of 1,382 | 20th |
Source: SEC filing on May 15, 2019.
Turkel's colleagues
We found two more compensation records of executives who worked with Catherine C. Turkel at Tokai Pharmaceuticals in 2018.